GlaxoSmithKline study highlights Corsodyl market leadership

GlaxoSmithKline has revealed data from a recent professional survey that underlines the market-leading qualities of its Corsodyl mouthwash.

The GlaxoSmithKline Consumer Healthcare poll revealed that Corsodyl is the number one recommended brand for the treatment of gum problems among dental care providers, reports industry publication Dentistry.

Around 99 percent of those polled said they trust Corsodyl as a treatment for patients with gingivitis, a common condition that affects 15 to 20 percent of the world's population, with this proportion being even higher among people in the UK.

GlaxoSmithKline is committed to raising awareness of the importance of gum health – and the significance of bleeding when brushing as an early sign of gingivitis – via the Corsodyl brand.

As part of this campaign, the company has made Corsodyl gum care packs available which contain education materials incorporating the Basic Periodontal Examination method.

The Corsodyl Treatment range includes mouthwash, spray and dental gel offerings, while the Daily range offers more standard day-to-day protection.